Eisai Co., Ltd.
4523 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 文京区小石川４丁目６番１０号
- Website:
- https://www.eisai.com/index.html
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Eisai Co., Ltd. is a global biopharmaceutical company based in Japan, dedicated to human health care. The company focuses on discovering, developing, and delivering innovative medicines to improve the quality of life for patients worldwide. Eisai is particularly noted for its commitment to addressing health challenges in developing and emerging countries, exemplified by its supply of lymphatic filariasis treatments to 32 countries, totaling 2.53 billion tablets as of June 2025. By prioritizing access to medicines, Eisai aims to contribute positively to global health and enhance the well-being of communities in need. Its ethos revolves around the belief that patients are at the heart of its operations, guiding its research and development efforts.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-19 09:25 |
Inside Information Statement
臨時報告書
|
Japanese | 31.9 KB | |
| 2025-06-13 04:30 |
Internal Control over Financial Reporting
内部統制報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 25.1 KB | |
| 2025-06-13 04:29 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-13 04:28 |
Annual Report
有価証券報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 5.2 MB | |
| 2025-06-03 08:00 |
Major Shareholding Notification
変更報告書
|
Japanese | 39.0 KB | |
| 2025-05-13 08:00 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 37.9 KB | |
| 2025-05-08 09:00 |
Regulatory News Service
公開買付報告書
|
Japanese | 41.0 KB | |
| 2025-04-01 08:00 |
Regulatory News Service
訂正公開買付届出書
|
Japanese | 177.2 KB | |
| 2025-03-17 06:00 |
Regulatory News Service
公開買付届出書
|
Japanese | 348.4 KB | |
| 2025-03-12 07:06 |
Inside Information Statement
臨時報告書
|
Japanese | 21.8 KB | |
| 2024-12-11 02:14 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.2 KB | |
| 2024-11-15 02:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 21.7 KB | |
| 2024-11-08 06:17 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | |
| 2024-11-08 06:16 |
Interim Report
半期報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 268.5 KB | |
| 2024-10-09 03:00 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |